Skip to main content

Brainstorm Cell Therapeutics Inc. - Common Stock (NQ: BCLI )

2.280 +0.200 (+9.62%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

Form 10-K/A
Source: SEC/Edgar
March 31, 2019
Form 8-K
Source: SEC/Edgar
March 11, 2019
Form S-8
Source: SEC/Edgar
December 20, 2018
Form 8-K
Source: SEC/Edgar
November 29, 2018
Form DEF 14A
Source: SEC/Edgar
October 09, 2018
Form 424B1
Source: SEC/Edgar
September 27, 2018
Form EFFECT
Source: SEC/Edgar
September 27, 2018
Form S-3/A
Source: SEC/Edgar
September 20, 2018
Form EFFECT
Source: SEC/Edgar
June 28, 2018
Form S-3
Source: SEC/Edgar
June 28, 2018
Form D
Source: SEC/Edgar
June 19, 2018
Form S-3
Source: SEC/Edgar
June 07, 2018
Form 424B3
Source: SEC/Edgar
June 06, 2018
Form 8-K
Source: SEC/Edgar
June 06, 2018
Form 8-K
Source: SEC/Edgar
February 04, 2018
Form 8-K
Source: SEC/Edgar
January 03, 2018
Form 8-K
Source: SEC/Edgar
November 12, 2017
Form 8-K
Source: SEC/Edgar
November 02, 2017
Form 8-K
Source: SEC/Edgar
July 25, 2017
Form 8-K
Source: SEC/Edgar
July 20, 2017
Form 8-K
Source: SEC/Edgar
March 05, 2017
Form 8-K
Source: SEC/Edgar
March 01, 2017
Form 8-K
Source: SEC/Edgar
December 18, 2016
Form 8-K
Source: SEC/Edgar
December 08, 2016
Form 8-K
Source: SEC/Edgar
December 04, 2016
Form EFFECT
Source: SEC/Edgar
November 20, 2016
Form POS AM
Source: SEC/Edgar
November 13, 2016
Form S-8
Source: SEC/Edgar
September 19, 2016
Form 424B3
Source: SEC/Edgar
August 11, 2016
Form 8-K
Source: SEC/Edgar
August 10, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.